Media
News & Events
Asceneuron to present at the AD/PD Conference in Vienna
Asceneuron to present at the 13th International Conference on Alzheimer’s and Parkinson’s Diseases on 29 March 2017 in Vienna, Austria.
J. Michael Ryan, M.D. appointed as Chief Medical Officer
Asceneuron today announced the appointment of J. Michael Ryan, M.D. as Chief Medical Officer. With over 15 years of Central Nervous System (CNS) clinical research experience, Michael brings extensive drug development expertise to Asceneuron. He will be responsible for advancing Asceneuron’s pipeline of innovative small molecules and progressing tau modifiers through the clinic.
Asceneuron to attend 2017 J.P. Morgan Healthcare Conference
Asceneuron to attend the 35th Annual J.P. Morgan Healthcare Conference taking place January 9-12, 2017 at the Westin St. Francis in San Francisco, CA.
Asceneuron to present a poster on the M1 PAM program
Asceneuron will present a poster on the M1 PAM program at the Society for Neuroscience (SfN) Annual Meeting 2016 on November 12-16, 2016 in San Diego, USA.
Asceneuron receives grant from The Michael J. Fox Foundation for Parkinson’s research
Asceneuron has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research for the further development of positive allosteric modulators of the M1 muscarinic acetylcholine receptor.
Asceneuron receives grant from The Michael J. Fox Foundation for Parkinson’s research
Asceneuron has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research for the further development of positive allosteric modulators of the M1 muscarinic acetylcholine receptor.
Meet Asceneuron at Bio-Europe 2016
Asceneuron to attend Bio-Europe partnering event on 7-9 November, 2016 in Cologne, Germany
Asceneuron to present at the 6th FTD UK Annual Meeting 2016
Asceneuron to present at the 6th FTD UK Annual Meeting 2016 on November 4, 2016 in Cambridge, United Kingdom.
International Conference on Alzheimer’s Drug Discovery
Asceneuron to present at the 17th International Conference on Alzheimer’s Drug Discovery on 12-13 September, 2016 in Jersey City, NJ, USA
10th International Conference on Frontotemporal Dementias
Asceneuron to take part in a panel discussion on clinical trials at the 10th International Conference on Frontotemporal Dementias on August 31 - September 2, 2016, in Munich, Germany